-
Emerging class of antibiotics to tackle global TB crisis
The rise of drug-resistant tuberculosis strains has made the search for new treatments increasingly urgent.
Article link
/content/dam/corporate/images/news-and-opinion/news/2026/february/generic-x-ray-of-tuberculosis-patient.-adobe-images.jpeg
1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 800.533.2x.jpeg 1600w, 220.147.2x.jpeg 440w
26 February 2026
-
Sugar molecules point to a new weapon against drug-resistant bacteria
A bacterial sugar becomes an unexpected Achilles' heel for deadly pathogens.
Article link
/content/dam/corporate/images/news-and-opinion/news/2026/february/antibody-binding-the-pse-sugar-to-target-bacteria-with-this-sugar-for-destruction---wehi.jpg
1280.1280.jpeg 1280w, 220.231.2x.jpeg 440w, 1440.1511.2x.jpeg 2880w, 440.462.2x.jpeg 880w, 800.839.2x.jpeg 1600w
5 February 2026
-
Sydney scholar Richard Payne honoured with Australian Laureate Fellowship
His research will investigate how proteins can advance the biotech and pharmaceutical sectors.
Article link
/content/dam/people/a.-professor-richard-payne-faa.-school-of-chemistry.-the-university-of-sydney.-newly-elected-as-a-fellow-of-the-australian-academy-of-science.-photo-by-stefanie-zingsheim.jpg
1280.1280.jpeg 1280w, 800.450.2x.jpeg 1600w, 440.247.2x.jpeg 880w, 220.124.2x.jpeg 440w
30 June 2025
-
Native bee honey has potential in the fight against antibiotic resistance
'Sugarbag' honey, historically used by First Nations peoples, could scale commercially.
Article link
/content/dam/corporate/images/news-and-opinion/news/2025/may/sugarbag-bee-beehives---tetragonula-carbonaria.-adobe-images.jpeg
1280.1280.jpeg 1280w, 1440.810.2x.jpeg 2880w, 440.248.2x.jpeg 880w, 800.451.2x.jpeg 1600w, 220.124.2x.jpeg 440w
23 June 2025
-
NSW Organoid Innovation Centre launches at Sydney
'Organs in a dish' technology to accelerate personalised medicine and drug discovery.
Article link
/content/dam/corporate/images/news-and-opinion/news/2025/april/nswoic-launch-26mar25-hugh-durrant-whyte-left-michael-kassiou-right.jpg
800.534.2x.jpeg 1600w, 2000.1334.2x.jpeg 4000w, 1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 220.147.2x.jpeg 440w
2 April 2025
-
Professor Michael Kassiou wins the 2024 AFR Research Commercialisation award
The University of Sydney awarded at the AFR Higher Education Awards this year, with Kinoxis Therapeutics as joint winner.
Article link
/content/dam/corporate/images/news-and-opinion/news/2024/august/img_3846(1).jpg
1440.790.2x.jpeg 2880w, 1280.1280.jpeg 1280w, 440.242.2x.jpeg 880w, 220.121.2x.jpeg 440w, 800.440.2x.jpeg 1600w
21 August 2024
-
Psylo partnership to deliver psychedelic treatments for mental health
A partnership between the University of Sydney Brain and Mind Centre and biotech startup Psylo will promises life-changing therapeutics for mental health treatment.
Article link
/content/dam/brand-and-marketing-assets/conceptual-images/abstract-serotonin-adobe-images.jpg
800.350.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 440.192.2x.jpeg 880w, 220.96.2x.jpeg 440w, 2000.1330.2x.jpeg 4000w
27 June 2024
-
Beyond CRISPR: seekRNA delivers a new pathway for accurate gene editing
Developed in the Ataide Laboratory at the University of Sydney, seekRNA is a programmable tool can precisely target and relocate genetic sequences, picking up from the work started by CRISPR gene-editing.
Article link
/content/dam/brand-and-marketing-assets/conceptual-images/artists-impression-rna-strand-adobe-images.jpg
1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 220.96.2x.jpeg 440w, 440.193.2x.jpeg 880w, 2000.1330.2x.jpeg 4000w, 800.351.2x.jpeg 1600w
25 June 2024
-
Drug discovery gets $9.75m boost for MedChem Australia
The University of Sydney will be one of three national nodes of MedChem Australia, established in partnership with Monash and WEHI Medical Research, which will accelerate early-stage drug discovery.
Article link
/content/dam/people/professor-michael-kassiou-in-his-labs.-school-of-chemistry.-university-of-sydney.-03may23.-photo-is-by-stefanie-zingsheim.jpg
1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.810.2x.jpeg 2880w, 800.450.2x.jpeg 1600w, 800.533.2x.jpeg 1600w, 440.248.2x.jpeg 880w, 220.147.2x.jpeg 440w, 220.124.2x.jpeg 440w
27 June 2023
-
AI drug discovery will power collaboration with Pharos Therapeutics
A partnership between the University of Sydney's Drug Discovery Initiative and Pharos Therapeutics will use artificial intelligence to more rapidly identify promising treatments for cancers and rare diseases.
Article link
/content/dam/alumni-community-and-industry-engagement/university-partnerships/julie-cairney-kyu-tae-kim-michael-kassiou-pharos-mou-may-2023.jpg
1280.1280.jpeg 1280w, 1440.810.2x.jpeg 2880w, 800.450.2x.jpeg 1600w, 440.248.2x.jpeg 880w, 220.124.2x.jpeg 440w
30 May 2023
-
Sydney spinout lands $273m deal to develop drugs for psychiatric disorders
Compounds that target oxytocin receptors in the brain are being developed into medicines to treat schizophrenia and other psychiatric disorders in a landmark $273m partnership between University of Sydney spinout Kinoxis and Boehringer.
Article link
/content/dam/people/crop-lowres-prof-michael-kassiou-(left)-and-associate-prof-michael-bowen-at-the-chau-chak-wing-museum.-03may23.-university-of-sydney.-photo-stefanie-zingsheim.jpg
800.350.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 220.96.2x.jpeg 440w, 440.193.2x.jpeg 880w
05 May 2023
-
NSW Government backs University-led consortium on drug discovery
Professor Michael Kassiou from the Drug Discovery Initiative and School of Chemistry will lead the NSW Organoid Innovation Centre, which will focus on stem-cell science to accelerate precision medicine.
Article link
/content/dam/intranet/images/medicine-and-health/news-and-events/2021/october-10/cortical-organoid-2.jpg
800.806.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 220.222.2x.jpeg 440w, 440.443.2x.jpeg 880w
01 March 2023
